Table 3.
Protein/Gene | Disease | Expression Change | Samples Evaluated | Citation(s) |
---|---|---|---|---|
MYL4, ACTN2, ACTA1, RTN4, MYOM1, ODC1, PAM | Dilated Cardiomyopathy | ↑ | 181 | [20], [21], [22], [23], [24], [25] |
MYL4, ACTN2, ACTA1, RTN4 | Ischemic Cardiomyopathy | ↑ | 57 | [20], [21], [25] |
FHL2 | Dilated Cardiomyopathy | ↓ | 73 | [24] |
FHL2 | Ischemic Cardiomyopathy | ↓ | 73 | [24] |
MYL4 | Congenital heart disease | ↑ | 27 | [26] |
MYL4, MYL6 | End stage LV failure | ↓ | 8a | [27] |
PFKM | Right heart failure | ↑ | 24b | [28] |
Samples are human unless otherwise denoted.
Dog samples;
Rat samples